journal article·2023-07Open access

Assessment of antibacterial properties and skin irritation potential of anodized aluminum impregnated with various quaternary ammonium

Jessica Jann, Suzanne Gascon, Olivier Drevelle, Julie Fradette, Myriam Auclair-Gilbert, Gervais Soucy, Louis-Charles Fortier, Nathalie Faucheux

Abstract

The importance of the inert environment in the transmission of pathogens has been reassessed in recent years. To reduce cross-contamination, new biocidal materials used in high touch surfaces (e.g., stair railings, door handles) have been developed. However, their impact on skin remains poorly described. The present study aimed to evaluate the antibacterial properties and the risk of skin irritation of two materials based on hard-anodized aluminum (AA) impregnated with quaternary ammonium compound solutions (QAC#1 or QAC#2). The QAC#1 or QAC#2 solutions vary in composition, QAC#2 being free of dioctyl dimethyl ammonium chloride (Dio-DAC) and octyl decyl dimethyl ammonium chloride (ODDAC). Unlike AA used as a control, both AA-QAC#1 and AA-QAC#2 had excellent and rapid antibacterial efficacy, killing 99.9 % of Staphylococcus aureus and Escherichia coli bacteria, in 15 s and 1 min, respectively. The impregnation solutions (QAC#1 and QAC#2) did not show any skin sensitizing effect on transformed human keratinocytes. Nevertheless, these solutions as well as the materials (AA-QAC#1, AA-QAC#2), and the liquid extracts derived from them, induced a very rapid cytotoxicity on L929 murine fibroblasts (>70 % after 1 h of contact) as shown by LDH, MTS and neutral red assays. This cytotoxicity can be explained by the fast QACs release occurring when AA-QAC#1 and AA-QAC#2 were immersed in aqueous medium. To overcome the limitation of assays based on liquid condition, an in vitro skin irritation assay on reconstructed human epidermis (RHE) was developed. The effect of the materials upon their direct contact with the epidermis grown at the liquid-air interface was determined by evaluating tissue viability and quantifying interleukin-1 alpha (IL-1α) which is released in skin during injury or infection. AA-QAC#1 induced a significant decrease in RHE viability, close to OECD and ISO 10993-10 acceptability thresholds and enhanced the pro-inflammatory IL-1α secretion compared with AA-QAC#2. Finally, these results were corroborated by in vivo assays on mice using erythema and edema visual scores, histological observations, and epidermal thickness measurement. AA had no effect on the skin, while a stronger irritation was induced by AA-QAC#1 compared with AA-QAC#2. Hence, these materials were classified as moderate and slight irritants, respectively. In summary, this study revealed that AA-QAC#2 without Dio-DAC and ODDAC could be a great candidate for high touch surface applications, showing an extremely effective and rapid bactericidal activity, without inducing adverse effects for skin tissue.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Contact Dermatitis and Allergies · Antimicrobial agents and applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Report on the burden of endemic health care-associated infection worldwide
2. Plan d’action mondial pour combattre la résistance aux antimicrobiens
3. No time to wait : securing the future from drug-resistant infections
4. 2019 · 1 · 1
5. 2017
6. The role of environmental contamination in the transmission of nosocomial pathogens and healthcare-associated infections10.1007/s11908-018-0620-2 ↗
7. The role played by contaminated surfaces in the transmission of nosocomial pathogens10.1086/660363 ↗
8. Quantitative characterization of high-touch surfaces in emergency departments and hemodialysis facilities10.1017/ice.2020.466 ↗
9. Self-disinfecting surfaces and infection control10.1016/j.colsurfb.2019.02.009 ↗
10. On the emergence of antibacterial and antiviral copper cold spray coatings10.1186/s13036-021-00256-7 ↗
11. Self-disinfecting surfaces : review of current methodologies and future prospects10.1016/j.ajic.2012.12.005 ↗
12. Green · 2014
13. Copper alloy touch surfaces in healthcare facilities: an effective solution to prevent bacterial spreading10.3390/ma11122479 ↗
14. Antimicrobial copper-based materials and coatings: potential multifaceted biomedical applications10.1021/acsami.9b17815 ↗
15. Specific antibacterial activity of copper alloy touch surfaces in five long-term care facilities for older adults10.1016/j.jhin.2019.11.021 ↗
16. Selection of resistance by antimicrobial coatings in the healthcare setting10.1016/j.jhin.2020.06.006 ↗
17. How much impact do antimicrobial surfaces really have on healthcare-acquired infection?10.1093/cid/ciz1078 ↗
18. Application of copper to prevent and control infection. Where are we now?10.1016/j.jhin.2012.05.009 ↗
19. Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review10.1016/j.jhin.2015.09.008 ↗
20. The role of copper surfaces in reducing the incidence of healthcare-associated infections: a systematic review and meta-analysis
21. Anodized aluminum with nanoholes impregnated with quaternary ammonium compounds can kill pathogenic bacteria within seconds of contact10.1021/acsami.8b17634 ↗
22. Rapid antibacterial activity of anodized aluminum-based materials impregnated with quaternary ammonium compounds for high-touch surfaces to limit transmission of pathogenic bacteria10.1039/D1RA07159A ↗
23. Morris · 1991
24. Jones · 1986
25. Allan · 1995
26. Assessment Report - Didecyldimethylammonium chloride product-type 8 (Wood Preservative)
27. Registration dossier for CAS number 7173-51-5
28. 2006 · 1
29. Moore · 1999
30. 2006 · 1
31. Toxicity studies: primary irritation study
32. Alkyl (C12–16) dimethylbenzyl ammonium chloride
33. Registration dossier for Dimethyldioctylammonium chloride (CAS number 5538-94-3)
34. ISO 10993-1 : Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
35. ISO 10993-5 : Biological evaluation of medical devices — part 5: tests for in vitro cytotoxicity
36. ISO 10993-12: Biological evaluation of medical devices
37. Cytotoxicity and transcriptomic analysis of silver nanoparticles in mouse embryonic fibroblast cells10.3390/ijms19113618 ↗
38. Analysis of cell viability by the lactate dehydrogenase assay
39. Characterization and cytotoxicity comparison of silver-and silica-based nanostructures10.3390/ma14174987 ↗
40. Selvestrel · 2022
41. In vitro methods for hazard assessment of industrial chemicals - opportunities and challenges10.3389/fphar.2015.00094 ↗
42. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment10.1016/j.tiv.2014.10.018 ↗
43. The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers-functional relevance and a hypothesis on innate reactions to skin sensitizers10.1093/toxsci/kfp228 ↗
44. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals10.1093/toxsci/kfm259 ↗
45. Test no. 442D: in vitro skin sensitisation - ARE-Nrf2 luciferase test method
46. Nrf2 activation as a key event triggered by skin sensitisers: the development of the stable keratinosens reporter gene assay10.1177/026119291604400513 ↗
47. Test no. 431: in vitro skin corrosion: reconstructed human epidermis (RHE) test method
48. ISO 10993-10 : biological evaluation of medical devices — part 10: tests for skin sensitization
49. OECD Guidelines for the testing of chemicals. TG 439. In Vitro skin irritation: reconstructed human epidermis test method
50. Evaluation of potential eye or skin irritation/corrosion in rabbit exposed to tio2 photocatalyst (Gst)
51. ISO 10993–2: biological evaluation of medical devices — part 2: animal welfare requirements
52. Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activation10.1007/s00403-012-1209-5 ↗
53. Methods for cultivation of keratinocytes with an air-liquid interface10.1111/1523-1747.ep12540324 ↗
54. A new reconstructed human epidermis for in vitro skin irritation testing10.1016/j.tiv.2017.03.010 ↗
55. Skin corrosion test: a comparison between reconstructed human epidermis and full thickness skin models10.1016/j.ejpb.2018.01.002 ↗
56. In Vitro skin irritation testing: improving the sensitivity of the epiderm skin irritation test protocol10.1177/026119290903700611 ↗
57. In vitro human skin irritation test for evaluation of medical device extracts10.1016/j.tiv.2013.08.006 ↗
58. Development of an in vitro corrosion/irritation prediction assay using the EpiDermTM skin model10.1016/j.tiv.2007.08.018 ↗
59. Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals10.1016/S0887-2333(99)00076-4 ↗
60. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–201710.1017/ice.2019.296 ↗
61. Dumont · 2021
62. 2020 · 1
63. Statistical study of the spot-plate technique for viable-cell counts10.1128/am.11.4.305-309.1963 ↗
64. Spot plating assay for the determination of survival and plating efficiency of escherichia coli in sub-MIC levels of antibiotics
65. Reporter cell lines for skin sensitization testing10.1007/s00204-015-1555-0 ↗
66. Wolfram Fürbeth anodizing—the pore makes the difference10.1002/maco.202213324 ↗
67. ISO 22196 : measurement of antibacterial activity on plastics and other non-porous surfaces
68. 2015 · 5
69. 2020 · 1
70. Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus10.1128/AAC.00375-06 ↗
71. ISO 18593:2018 microbiology of the food chain — horizontal methods for surface sampling
72. 2015
73. Hand-touch contact assessment of high-touch and mutual-touch surfaces among healthcare workers, patients, and visitors10.1016/j.jhin.2014.12.024 ↗
74. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro10.1016/j.taap.2010.03.009 ↗
75. Assessment of the different skin sensitization potentials of irritants and allergens as single substances and in combination using the KeratinoSens assay10.1111/cod.13762 ↗
76. Application of the KeratinoSensTM assay for assessing the skin sensitization potential of agrochemical active ingredients and formulations10.1016/j.yrtph.2015.05.006 ↗
77. BARDAC-22: Test to evaluate the sensitizing potential by topical applications in the guinea pig
78. Kukulinski · 2003
79. Potential designated chemicals: quaternary ammonium compounds
80. Dimethyldioctylammonium chloride
81. Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride10.3109/1547691X.2016.1140854 ↗
82. Topical application of the quaternary ammonium compound didecyldimethylammonium chloride activates type 2 innate lymphoid cells and initiates a mixed-type allergic response10.1093/toxsci/kfz002 ↗
83. Contact dermatitis from didecyldimethylammonium chloride and bis-(aminopropyl)-laurylamine in a detergent-disinfectant used in hospital10.1111/j.1600-0536.1997.tb00050.x ↗
84. Occupational allergic contact dermatitis from N, N-bis(3-aminopropyl)dodecylamine and dimethyldidecylammonium chloride in 2 hospital staff10.1034/j.1600-0536.2001.045001040.x ↗
85. Airborne allergic contact dermatitis caused by didecyldimethylammonium chloride in a geriatric nurse10.1111/cod.12013 ↗
86. Foot dermatitis caused by didecyldimethylammonium chloride in a shoe refresher spray10.1111/cod.12456 ↗
87. Patch testing with didecyldimethylammonium chloride10.1111/cod.12539 ↗
88. Contact sensitizations to disinfectants containing alcohols or quaternary ammonium compounds are rarely of clinical relevance10.1111/cod.13844 ↗
89. Human health hazard assessment of quaternary ammonium compounds: didecyl dimethyl ammonium chloride and alkyl (C12–C16) dimethyl benzyl ammonium chloride10.1016/j.yrtph.2020.104717 ↗
90. Cytotoxicity and molecular effects of biocidal disinfectants (quaternary ammonia, glutaraldehyde, poly(hexamethylene biguanide) hydrochloride PHMB) and their mixtures in vitro and in zebrafish eleuthero-embryos10.1016/j.scitotenv.2017.02.114 ↗
91. Adverse outcome pathway for antimicrobial quaternary ammonium compounds10.1080/15287394.2022.2037479 ↗
92. Modes of action of three disinfectant active substances: a review10.1016/j.yrtph.2013.09.006 ↗
93. Cationic antiseptics: diversity of action under a common epithet10.1111/j.1365-2672.2005.02664.x ↗
94. Report on investigation of ISO 10993–12 extraction conditions10.1016/j.yrtph.2022.105164 ↗
95. A comparative study of skin irritation caused by novel bis-quaternary ammonium compounds and commonly used antiseptics by using cell culture methods10.1016/j.tiv.2018.09.009 ↗
96. Griesinger · 2009
97. Effect of skin barrier competence on SLS and water-induced IL-1α expression10.1034/j.1600-0625.2001.110304.x ↗
98. Analysis of interleukin-1α (IL-1α) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization10.1016/S0887-2333(03)00019-5 ↗
99. International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive capacity10.14573/altex.1308021 ↗
100. Novel cytokine marker available for skin irritation testing of medical devices using reconstructed human epidermis models10.1016/j.tiv.2020.104919 ↗